The Immersive Experience of Virtual Reality During Chemotherapy in Patients With Early Breast and Gynecological Cancers: the Patient's Dream Study

Inclusion Criteria

• •diagnosis of breast or ovarian cancer confirmed histologically, from I to III stage;
• •surgery as first therapeutic approach (in case of ovarian cancer, patients with minimal residual disease after surgery will be also included)
• •first cycle of adjuvant CT, with or without a biological treatment according to the specific cancer (regimens including anthracyclines/taxanes, anthracyclines/cyclophosphamide, carboplatinum/taxane combined or not with trastuzumab for breast cancer, carboplatin/paclitaxel combined or not with bevacizumab for ovarian cancer);
• •aged ≥ 18 years;
• •performance status (ECOG) 0-2;
• •life expectancy \> 12 months;
• •ability to understand and sign the informed consent.